Wolfgang Miesbach Honors Glenn Pierce for His Insights into Hemophilia Care at BIC 2025
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”The future isn’t just about new technologies – it’s about equitable distribution of life-changing treatments worldwide.
Glenn Pierce, VP Medical at WFH delivered a powerful presentation at BIC 2025 that perfectly captures both the achievements and the challenges in haemophilia care.
The remarkable progress so far:
- Innovation is advancing toward a haemophilia-free mind
- Increasing proportion of patients achieving zero bleeds
- Decreased treatment burden and improved quality of life
- Better short and long-term outcomes (though still proving some benefits)
But the reality of global inequity persists:
– High-income countries (16% of population) consume 50% of FVIII products
– Low-income countries (9% of population) access only 0.4% of products
– Lower-middle-income countries (58% of population) use just 7% of available treatments
Looking ahead: The treatment innovation cycle shows promise with gene therapy, extended half-life products, and new technologies positioned at different income levels. Yet we still need concentrated global effort to address unmet needs for the majority of the world’s haemophilia population.”
‘
More from BIC 2025 featured in Hemostasis Today.
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy